BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang H, Zeng L, Wang J, Zhang X, Ruan Q, Wang J, Cui S, Yang D. Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer. Oncotarget. 2017;8:82842-82853. [PMID: 29137307 DOI: 10.18632/oncotarget.20666] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Gao Q, Feng J, Liu W, Wen C, Wu Y, Liao Q, Zou L, Sui X, Xie T, Zhang J, Hu Y. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev 2022;188:114445. [PMID: 35820601 DOI: 10.1016/j.addr.2022.114445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Michel O, Szlasa W, Baczyńska D, Saczko J, Tarek M, Kulbacka J. The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance proteins. Bioelectrochemistry 2022;147:108199. [PMID: 35841647 DOI: 10.1016/j.bioelechem.2022.108199] [Reference Citation Analysis]
3 Ng CX, Affendi MM, Chong PP, Lee SH. The Potential of Plant-Derived Extracts and Compounds to Augment Anticancer Effects of Chemotherapeutic Drugs. Nutr Cancer 2022;:1-19. [PMID: 35675271 DOI: 10.1080/01635581.2022.2069274] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Persano F, Gigli G, Leporatti S. Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas. IJMS 2022;23:3360. [DOI: 10.3390/ijms23063360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yu L, Li Y, Wang H, Wang D, Hao H, Zhang D, Liang X, Cai M, Guan R, Bai J, Yu J. The functional variant in promoter of OVCA1 was associated with the risk of gastric cancer in the northeast Chinese Han population. Pathol Res Pract 2021;230:153755. [PMID: 34990869 DOI: 10.1016/j.prp.2021.153755] [Reference Citation Analysis]
6 Szymczyk J, Sluzalska KD, Materla I, Opalinski L, Otlewski J, Zakrzewska M. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance. Cancers (Basel) 2021;13:5796. [PMID: 34830951 DOI: 10.3390/cancers13225796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Roshanazadeh M, Babaahmadi Rezaei H, Rashidi M. Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line. Iran J Basic Med Sci 2021;24:928-34. [PMID: 34712423 DOI: 10.22038/ijbms.2021.56559.12629] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines 2021;9:1353. [PMID: 34680470 DOI: 10.3390/biomedicines9101353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shah D, Gandhi M, Kumar A, Cruz-Martins N, Sharma R, Nair S. Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention. Crit Rev Food Sci Nutr 2021;:1-37. [PMID: 34433338 DOI: 10.1080/10408398.2021.1968786] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
10 Chen Y, Cheng S, Dai J, Wang L, Xu Y, Peng X, Xie X, Peng C. Molecular mechanisms and applications of tea polyphenols: A narrative review. J Food Biochem 2021;45:e13910. [PMID: 34426979 DOI: 10.1111/jfbc.13910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bhaskaran NA, Kumar L. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. J Control Release 2021;336:16-39. [PMID: 34118336 DOI: 10.1016/j.jconrel.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu Z, Wang Y, Xu Z, Yuan S, Ou Y, Luo Z, Wen F, Liu J, Zhang J. Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR. PeerJ 2021;9:e11429. [PMID: 34113488 DOI: 10.7717/peerj.11429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Han JH, Kim M, Kim HJ, Jang SB, Bae SJ, Lee IK, Ryu D, Ha KT. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil. Int J Mol Sci 2021;22:5406. [PMID: 34065602 DOI: 10.3390/ijms22105406] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Beck AC, Cho E, White JR, Paemka L, Li T, Gu VW, Thompson DT, Koch KE, Franke C, Gosse M, Wu VT, Landers SR, Pamatmat AJ, Kulak MV, Weigel RJ. AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer. Mol Cancer Res 2021;19:1156-67. [PMID: 33753551 DOI: 10.1158/1541-7786.MCR-20-0867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ding F, Yang S. Epigallocatechin-3-gallate inhibits proliferation and triggers apoptosis in colon cancer via the hedgehog/phosphoinositide 3-kinase pathways. Can J Physiol Pharmacol 2021;99:910-20. [PMID: 33617370 DOI: 10.1139/cjpp-2020-0588] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother 2021;137:111285. [PMID: 33485118 DOI: 10.1016/j.biopha.2021.111285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
17 Zhang M, Chen X, Radacsi N. New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies. J Control Release 2021;329:96-120. [PMID: 33259852 DOI: 10.1016/j.jconrel.2020.11.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
18 Tong H, Huang Z, Chen H, Zhou B, Liao Y, Wang Z. Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway. Onco Targets Ther 2020;13:9839-48. [PMID: 33061461 DOI: 10.2147/OTT.S253691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Wang XY, Zhou YC, Wang Y, Liu YY, Wang YX, Chen DD, Fan Y. miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway. Biochem Biophys Res Commun 2020;532:329-35. [PMID: 32977944 DOI: 10.1016/j.bbrc.2020.05.135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sun Z, Luan S, Yao Y, Qin T, Xu X, Shen Z, Yao R, Yue L. NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway. Onco Targets Ther 2020;13:8521-32. [PMID: 32904684 DOI: 10.2147/OTT.S256274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Garg N, Joshi R, Medhi B. A novel approach of targeting refractory epilepsy: Need of an hour. Brain Res Bull 2020;163:14-20. [PMID: 32679059 DOI: 10.1016/j.brainresbull.2020.07.012] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y, Xu P. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Front Cell Dev Biol 2020;8:565. [PMID: 32766241 DOI: 10.3389/fcell.2020.00565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
23 Almatroodi SA, Almatroudi A, Khan AA, Alhumaydhi FA, Alsahli MA, Rahmani AH. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules 2020;25:E3146. [PMID: 32660101 DOI: 10.3390/molecules25143146] [Cited by in Crossref: 16] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
24 Chen L, Guo X, Hu Y, Li L, Liang G, Zhang G. Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate. FEBS Open Bio 2020;10:1403-13. [PMID: 32475087 DOI: 10.1002/2211-5463.12905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Cao S, Han Y, Li Q, Chen Y, Zhu D, Su Z, Guo H. Mapping Pharmacological Network of Multi-Targeting Litchi Ingredients in Cancer Therapeutics. Front Pharmacol 2020;11:451. [PMID: 32390834 DOI: 10.3389/fphar.2020.00451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sharifi-Rad M, Pezzani R, Redaelli M, Zorzan M, Imran M, Ahmed Khalil A, Salehi B, Sharopov F, Cho WC, Sharifi-Rad J. Preclinical Pharmacological Activities of Epigallocatechin-3-gallate in Signaling Pathways: An Update on Cancer. Molecules 2020;25:E467. [PMID: 31979082 DOI: 10.3390/molecules25030467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]
27 Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, Zhao M, Liu Q, Cheng Z, Zou J, Yao P, Gao C, Wei J, Ung COL, Wang S, Zhong Z, Wang Y. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med 2019;14:48. [PMID: 31719837 DOI: 10.1186/s13020-019-0270-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 141] [Article Influence: 22.7] [Reference Citation Analysis]
28 Li Q, Ren L, Zhang Y, Gu Z, Tan Q, Zhang T, Qin M, Chen S. P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin. Biomed Res Int 2019;2019:6407210. [PMID: 31781632 DOI: 10.1155/2019/6407210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zhang W, Zhang W, Sun L, Xiang L, Lai X, Li Q, Sun S. The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer. Trends in Food Science & Technology 2019;93:221-33. [DOI: 10.1016/j.tifs.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
30 Wang R, Huang J, Chen J, Yang M, Wang H, Qiao H, Chen Z, Hu L, Di L, Li J. Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles. Nanomedicine 2019;21:102068. [PMID: 31374249 DOI: 10.1016/j.nano.2019.102068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
31 Hou G, Yuan X, Li Y, Hou G, Liu X. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway. Invest New Drugs 2020;38:329-39. [PMID: 31102118 DOI: 10.1007/s10637-019-00781-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
32 Jingyue S, Xiao W, Juanmin Z, Wei L, Daoming L, Hong X. TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells. Mol Med Rep 2019;20:323-31. [PMID: 31115533 DOI: 10.3892/mmr.2019.10237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
33 Liu C, Li P, Qu Z, Xiong W, Liu A, Zhang S. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors. Molecules 2019;24:E1726. [PMID: 31058847 DOI: 10.3390/molecules24091726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
34 Cui XL, Li KJ, Ren HX, Zhang YJ, Liu XD, Bu BG, Wang L. Extract of Cycas revoluta Thunb. enhances the inhibitory effect of 5-fluorouracil on gastric cancer cells through the AKT-mTOR pathway. World J Gastroenterol 2019; 25(15): 1854-1864 [PMID: 31057299 DOI: 10.3748/wjg.v25.i15.1854] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 La X, Zhang L, Li Z, Li H, Yang Y. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway. J Agric Food Chem 2019;67:2510-8. [PMID: 30741544 DOI: 10.1021/acs.jafc.8b06665] [Cited by in Crossref: 32] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
36 Zhang J, Song J, Liang X, Yin Y, Zuo T, Chen D, Shen Q. Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance. Nanomedicine 2019;14:447-64. [DOI: 10.2217/nnm-2018-0244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
37 Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou M, Haq IU, Mariyam Z, Feng Q. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. Molecular Carcinogenesis 2018;57:1835-44. [DOI: 10.1002/mc.22901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]